Functional and Biological Determinants Affecting the Duration of Action and Efficacy of Anti-(+)-methamphetamine Monoclonal Antibodies in Rats

Ítems similars

• Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period
  per: Hambuchen, Michael D., et al.
  Publicat: (2014)
• Gestation Time-Dependent Pharmacokinetics of Intravenous (+)-Methamphetamine in Rats
  per: White, Sarah, et al.
  Publicat: (2011)
• Customizing Monoclonal Antibodies for the Treatment of Methamphetamine Abuse: Current and Future Applications
  per: Peterson, Eric C., et al.
  Publicat: (2014)
• Monoclonal Antibodies as Pharmacokinetic Antagonists for the Treatment of (+)-Methamphetamine Addiction
  per: Owens, S. Michael, et al.
  Publicat: (2011)
• Treatment with a Monoclonal Antibody against Methamphetamine and Amphetamine Reduces Maternal and Fetal Rat Brain Concentrations in Late Pregnancy
  per: White, Sarah J., et al.
  Publicat: (2014)